Paper36909316
Fibroblast growth factor 21 is expressed and secreted from skeletal muscle following electrical stimulation via extracellular ATP activation of the PI3K/Akt/mTOR signaling pathway.
Arias-Calderón M and 7 others. Front Endocrinol (Lausanne), 2023. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Fibroblast growth factor 21 is expressed and secreted from skeletal muscle following electrical stimulation via extracellular ATP activation of the PI3K/Akt/mTOR signaling pathway. Papers, record 36909316. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36909316
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fibroblast growth factor 21 is expressed and secreted from skeletal muscle following electrical stimulation via extracellular ATP activation of the PI3K/Akt/mTOR signaling pathway.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proto-Oncogene Proteins c-akt | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Muscle, Skeletal | |
| Signal Transduction | |
| TOR Serine-Threonine Kinases | |
| Adenosine Triphosphate | |
| Electric Stimulation | |
| Fibroblast Growth Factors |
Source PubMed
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29424246 | Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats. | Diab Vasc Dis Res | 2018 | https://conductscience.org/library/papers/29424246 | PubMed |
| 2 | 31453723 | Effect of exercise intensity on circulating hepatokine concentrations in healthy men. | Appl Physiol Nutr Metab | 2019 | https://conductscience.org/library/papers/31453723 | PubMed |
| 3 | 26545760 | Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release. | Purinergic Signal | 2016 | https://conductscience.org/library/papers/26545760 | PubMed |
| 4 | 31248786 | Going Back to the Biology of FGF21: New Insights. | Trends Endocrinol Metab | 2019 | https://conductscience.org/library/papers/31248786 | PubMed |
| 5 | 27069569 | Characterization of a multiprotein complex involved in excitation-transcription coupling of skeletal muscle. | Skelet Muscle | 2016 | https://conductscience.org/library/papers/27069569 | PubMed |
| 6 | 35498801 | Circulating FGF21 and GDF15 as Biomarkers for Screening, Diagnosis, and Severity Assessment of Primary Mitochondrial Disorders in Children. | Front Pediatr | 2022 | https://conductscience.org/library/papers/35498801 | PubMed |
| 7 | 25055037 | FGF21 expression and release in muscle cells: involvement of MyoD and regulation by mitochondria-driven signalling. | Biochem J | 2014 | https://conductscience.org/library/papers/25055037 | PubMed |
| 8 | 11328886 | A new mathematical model for relative quantification in real-time RT-PCR. | Nucleic Acids Res | 2001 | https://conductscience.org/library/papers/11328886 | PubMed |
| 9 | 35286020 | Effects of exercise intensity on white adipose tissue browning and its regulatory signals in mice. | Physiol Rep | 2022 | https://conductscience.org/library/papers/35286020 | PubMed |
| 10 | 18252893 | Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. | Diabetes | 2008 | https://conductscience.org/library/papers/18252893 | PubMed |
| 11 | 18948104 | FGF21 is an Akt-regulated myokine. | FEBS Lett | 2008 | https://conductscience.org/library/papers/18948104 | PubMed |
| 12 | 24282497 | Electrical stimuli are anti-apoptotic in skeletal muscle via extracellular ATP. Alteration of this signal in Mdx mice is a likely cause of dystrophy. | PLoS One | 2013 | https://conductscience.org/library/papers/24282497 | PubMed |
| 13 | 26379627 | FGF21 and Cardiac Physiopathology. | Front Endocrinol (Lausanne) | 2015 | https://conductscience.org/library/papers/26379627 | PubMed |
| 14 | 29632021 | Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency. | EMBO J | 2018 | https://conductscience.org/library/papers/29632021 | PubMed |
| 15 | 28607005 | OPA1 deficiency promotes secretion of FGF21 from muscle that prevents obesity and insulin resistance. | EMBO J | 2017 | https://conductscience.org/library/papers/28607005 | PubMed |
| 16 | 26415590 | Fibroblast growth factor-21, energy balance and obesity. | Mol Cell Endocrinol | 2015 | https://conductscience.org/library/papers/26415590 | PubMed |
| 17 | 25215270 | FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases. | Diabetes Metab J | 2014 | https://conductscience.org/library/papers/25215270 | PubMed |
| 18 | 26898145 | Regulation of myokine expression: Role of exercise and cellular stress. | Free Radic Biol Med | 2016 | https://conductscience.org/library/papers/26898145 | PubMed |
| 19 | 19822518 | ATP released by electrical stimuli elicits calcium transients and gene expression in skeletal muscle. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19822518 | PubMed |
| 20 | 32755998 | Fibroblast growth factor-21 potentiates glucose transport in skeletal muscle fibers. | J Mol Endocrinol | 2020 | https://conductscience.org/library/papers/32755998 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42352316 | Potential Influence of Myokines on Skeletal Muscle Tissue Hypertrophy Signaling Pathways: A Narrative Review. | Biomolecules | 2026 | https://conductscience.org/library/papers/42352316 | PubMed |
| 42315824 | Exercise-induced myokines in metabolic regulation: mechanisms, mimetics, and translational potential. | Arch Pharm Res | 2026 | https://conductscience.org/library/papers/42315824 | PubMed |
| 42011488 | Recent advances in electroactive biomaterials and electrical stimulation for skeletal muscle regeneration: materials, strategies, and mechanistic insights. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42011488 | PubMed |
| 41943063 | Exercise-myokine relationships in osteoarthritis. | J Transl Med | 2026 | https://conductscience.org/library/papers/41943063 | PubMed |
| 41727275 | Advances in electrical stimulation-based therapeutic technologies for sarcopenia prevention and treatment. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41727275 | PubMed |
| 41406482 | Effect of Muscle Contraction Under Caloric Restriction on Irisin and FGF21 Secretion in Mice. | Physiol Res | 2025 | https://conductscience.org/library/papers/41406482 | PubMed |
| 41346471 | Advances in electrical stimulation for wound healing. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/41346471 | PubMed |
| 41301412 | Cisplatin-Induced Skeletal Muscle Atrophy: Biomolecular Mechanisms and the Protective Role of Exercise-Induced Myokines. | Biomolecules | 2025 | https://conductscience.org/library/papers/41301412 | PubMed |
| 40886940 | The role of FGF21 in the metabolic adjustments required for exercise capacity. | Life Sci | 2025 | https://conductscience.org/library/papers/40886940 | PubMed |
| 40801027 | Exerkines and myokines in aging sarcopenia. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40801027 | PubMed |
| 40785685 | Protective effects of exerkine on cardiovascular system. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | https://conductscience.org/library/papers/40785685 | PubMed |
| 40782287 | Prominent fibroblast growth factor 21 with less abundant tumor-associated macrophages in hepatic mass of the conditional mgmt-deleted mice using LysM-Cre system. | Inflamm Res | 2025 | https://conductscience.org/library/papers/40782287 | PubMed |
| 40708814 | Conductive biological materials for in vitro models: properties and sustainability implications. | In Vitro Model | 2025 | https://conductscience.org/library/papers/40708814 | PubMed |
| 40527315 | FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression. | Cell Metab | 2025 | https://conductscience.org/library/papers/40527315 | PubMed |
| 40437610 | Bridging systemic metabolic dysfunction and Alzheimer's disease: the liver interface. | Mol Neurodegener | 2025 | https://conductscience.org/library/papers/40437610 | PubMed |
| 38673797 | Glucosamine Enhancement of Learning and Memory Functions by Promoting Fibroblast Growth Factor 21 Production. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38673797 | PubMed |
| 38069273 | Fibroblast Growth Factor 21: A Fascinating Perspective on the Regulation of Muscle Metabolism. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38069273 | PubMed |
| 37951850 | Potential role of Akt in the regulation of fibroblast growth factor 21 by berberine. | J Nat Med | 2024 | https://conductscience.org/library/papers/37951850 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| FGF21 | 26291 | PubTator's text mining | https://conductscience.org/library/genes/26291 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| MFSD11 | 79157 | PubTator's text mining | https://conductscience.org/library/genes/79157 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36909316
GET https://conductscience.org/api/papers/v1/36909316/references?page=2